Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
Prolonged viral prophylaxis helps limit reactivation events after cord blood transplantation

Prolonged viral prophylaxis helps limit reactivation events after cord blood transplantation

From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
Science Spotlight - May 18, 2020
Bezos family gives $35 million to Fred Hutch

Bezos family gives $35 million to Fred Hutch

Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland
News Releases - March 30, 2017
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
Hutch News - December 03, 2015
Gratitude, guilt and surviving cancer

Gratitude, guilt and surviving cancer

<p>Living through cancer is life-changing — often in unimagined and challenging ways, says leukemia survivor Jessie Quinn</p>
Hutch News - January 26, 2015
'It made me more grateful'

'It made me more grateful'

An extraordinary girl contends with a rare, life-threatening blood disease — and undergoes a made-to-order clinical study in cord-blood transplantation
Hutch News - January 05, 2015
Last Modified, April 02, 2020